Diagnostic chain operator Thyrocare Technologies (NSE:THYROCARE, BOM:539871) has agreed to invest an additional $25,000 in its joint venture company Thyrocare Laboratories (Tanzania), according to a Monday filing to the Indian stock exchanges,
Following the investment and on the allotment of shares by the JV company, Thyrocare Laboratories (Tanzania) will become a subsidiary of the company.
The joint venture company provides diagnostic and healthcare services directly to customers in Tanzania.
Price (INR): ₹659.50, Change: ₹-3.6, Percent Change: -0.54%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.